Products

LatePay Slayer

Stop chasing invoices.Get paid faster.

latepay.lucentpath.info Finance / Invoicing & Payments

AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
$29/mo
Higher than 79% of peersNiche median $10.79/mo
Creators
Asmodeay Helel
No social account linked
Launched
4mo ago
2026-07-14 · Est.

Traffic

Last 12 months
Monthly visitsData through Oct 2026
Events1 marketing move

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on Product HuntLaunch

    Automated invoice tracking and recovery

    Jul 14 · 4mo agoLaunch page

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority —Domain registered 2025-10-03

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

Starter
$29/mo

Trial: Start with a 60-day free trial. · 1 paid tier ($29) · Observed 2026-11-07 · Source page

Entry price $29/mo, Higher than 79% of peers; “Invoicing & Payments” median is $10.79/mo.View pricing benchmark

Pages & changes

Tracked since 2026-07-14

Key pages

Weekly snapshots
Home
latepay.lucentpath.info/ Snapshot 2026-11-07

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much does LatePay Slayer cost?
Starter: $29/mo. Observed 2026-11-07. Check the source for current billing terms, usage limits and taxes.Source
How much website traffic does LatePay Slayer get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is LatePay Slayer and what platforms does it support?
LatePay Slayer is catalogued under Invoicing & Payments: Stop chasing invoices.Get paid faster. Supported platforms: Web.

Related products in this category

Finance / Invoicing & Payments

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.